Side-by-side financials for ATOS and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATOS | NVS |
|---|---|---|
| Market cap | - | $293.12 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $1.76K | - |
| Net income (latest FY) | -$34.77M | - |
| Net margin | -1977815.7% | - |
| SEC filings | 634 | 947 |
Full pages: ATOSSA THERAPEUTICS, INC. and Novartis AG, or browse the full rankings.